Risk Stratification in the Emergency Department in Acutely Ill Older Patients
NCT ID: NCT02946398
Last Updated: 2019-07-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
600 participants
OBSERVATIONAL
2016-07-14
2019-07-06
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We aim to identify early risk factors associated with an adverse outcome in elderly patients who visit the emergency department (ED). Second, we aim to find practical tools to identify those elderly patients who are at risk for an adverse outcome in an early stage (by applying and testing triage and risk stratification scores, clinical impression and laboratory results).
With the results of this study, we intend to develop a clinical prediction model to identify older emergency department patients with an increased risk of adverse outcomes.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Triage Assessment and NEWS-score as Risk Predictor in Older Frailty Adults in the ED
NCT03783234
Geriatric Emergency Department Fall Injury Prevention Project
NCT05807724
Evaluation of Prioritized Assessment for Older Patients Living With Frailty Presenting to the Emergency Department
NCT06869148
Continuity of the Therapeutic Limitation Code: Analysis of the Variables of Admission in the Emergency Service That Are Associated With a Therapeutic Limitation Upon Exit
NCT02682979
Risk for Short-term Adverse Events in Older Emergency Department Users
NCT03964311
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Elderly patients (≥65 years of age) constitute an increasing population in emergency departments (EDs) in many countries. These patients are largely different from younger patients and undoubtedly need different approaches in acute care. Commonly used triage systems are not validated in elderly patients. We hypothesize that this factor contributes to a lack of recognition of patients at risk for adverse events or death.
Aim of the study:
* At first, we will try to identify early risk factors associated with adverse outcome such as age, the premorbid state (comorbidity, living status and cognitive/functional state), medication use, vital signs, and number of previous visits to the ED.
* Secondly, we will investigate the discriminating power of several triage and risk stratification scores. In our study, we will retrieve and validate the following triage and risk stratification scores: The Manchester Triage System (MTS) triage score, the Acute Physiology and Chronic Health Evaluation II (APACHE II) score and the Identification of Seniors At Risk-Hospitalised Patients (ISAR-HP) score for all hospitalized patients. Furthermore, we will calculate four well-known disease specific stratification scores: The Glasgow-Blatchford Bleeding (GBS Score) for patients with an upper gastrointestinal bleeding, the Abbreviated Mortality ED Sepsis (abbMEDS) score and Sepsis-related Organ Failure Assessment (SOFA) score and the Confusion, Urea, Respiration, Blood pressure, Age \>65 years (CURB-65) score.
* Thirdly, we will investigate the predictive value of the clinical impression of professionals (doctor/nurse) and the disease perception of patient/companion.
* Fourth, we will investigate the predictive value of laboratory tests (routine tests and biomarkers like lactate, N-terminal pro-B-type natriuretic peptide (NT-pro-BNP), high-sensitivity troponin (hs-TnT), procalcitonin (PCT) and d-dimer.
* At last, we intend to develop a clinical prediction model for short-term mortality and test the predictive ability of this model for the other adverse outcomes/endpoints. This model will be validated in an external cohort.
Study procedure:
The design is a multi-center prospective observational cohort study. The study will take place in Zuyderland MC in Heerlen and Maastricht UMC+ in the Netherlands. On presentation to the ED the patients will be given information about the study and informed consent will be signed. The patient or family member/companion, the nurse and the doctor will be asked to fill out a questionnaire in the ED (5 questions for patient/family and 9 questions for doctor or nurse). These questions will be used for evaluation of the clinical impression of the doctor/nurse and disease perception by the patient/companion. At the ED, 2 extra venous samples and one arterial blood gas sample will be taken in patients participating in the study in Zuyderland M.C. Blood gas analysis will take place immediately and the results will be presented to the attending doctor. Analysis of the biomarkers from the venous blood samples will take place after a few weeks and the results will be blinded in this study. Routine laboratory test will be analyzed in both hospitals. During the days and weeks after inclusion, data will be obtained from patients medical records. During the days and weeks after inclusion, data will be obtained from patients medical records. All patients will be followed up for 30 days and if possible for one year.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
elderly patients who visit the ED
elderly patients (65 years and older) who present to the emergency department for internal medicine or gastroenterology
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Visit to the emergency department for the internist/gastroenterologist
* Informed consent
Exclusion Criteria
* No informed consent
* Inability to speak Dutch or English
* Admission to a ward of another specialty than internal medicine/gastroenterology
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zuyderland Medisch Centrum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jacqueline Buijs
Internist
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jacqueline Buijs, dr.
Role: PRINCIPAL_INVESTIGATOR
Zuyderland M.C.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zuyderland Medisch Centrum
Heerlen, Limburg, Netherlands
Maastricht UMC+
Maastricht, Limburg, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Zelis N, Hundscheid R, Buijs J, De Leeuw PW, Raijmakers MT, van Kuijk SM, Stassen PM. Value of biomarkers in predicting mortality in older medical emergency department patients: a Dutch prospective study. BMJ Open. 2021 Jan 31;11(1):e042989. doi: 10.1136/bmjopen-2020-042989.
Zelis N, Huisman SE, Mauritz AN, Buijs J, de Leeuw PW, Stassen PM. Concerns of older patients and their caregivers in the emergency department. PLoS One. 2020 Jul 9;15(7):e0235708. doi: 10.1371/journal.pone.0235708. eCollection 2020.
Zelis N, Buijs J, de Leeuw PW, van Kuijk SMJ, Stassen PM. Study protocol for a multicentre prospective cohort study to identify predictors of adverse outcome in older medical emergency department patients (the Risk Stratification in the Emergency Department in Acutely Ill Older Patients (RISE UP) study). BMC Geriatr. 2019 Mar 4;19(1):65. doi: 10.1186/s12877-019-1078-2.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
NL55867.096.15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.